iX Biopharma Ltd announced that it has allotted and issued 633,600 new ordinary shares on Mar, 19 2026 following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share.

With the latest issuance, the company’s total share capital has risen to about 1,038.24 million shares from approximately 1,037.61 million shares.

The newly issued shares will rank pari passu with existing shares and are expected to commence trading on the Singapore Exchange Securities Trading Limited on or around Mar, 23 2026.

To date, a cumulative 7,484,199 warrants—about 13.01% of all warrants originally issued—have been exercised. The company said 50,025,280 warrants remain outstanding, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.